INTS9

Integrator complex subunit 9 · Q9NV88 · INTS9 on Sugi Atlas →

0 patent compounds predicted against INTS9, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to INTS9 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor PHASE1/PHASE2NOT_YET_RECRUITING
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Inter-regional Project of the Great Western Exploration Approach for Exome Molecular Causes Severe Intellectual Disability Isolated or Syndromic nanCOMPLETED
Chromosome 9 P Minus Syndrome nanRECRUITING
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes nanRECRUITING
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands nanCOMPLETED
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases nanNOT_YET_RECRUITING
Diet Intervention and GEnetic STudy (DIGEST-Pilot) nanUNKNOWN
A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
A Study of Multilocus Methylation Abnormalities in Subjects With Imprinting Disorders nanNOT_YET_RECRUITING
Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension nanNOT_YET_RECRUITING
Expression of TET1 Gene in Acute Leukaemia nanUNKNOWN
The Contribution of Optical Mapping to the Characterization of Chromosomal Rearrangements in Patients With Neurodevelopmental Disorders nanRECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis nanCOMPLETED
PREcision Diagnostics in Rare genetIC Diseases and Tumors - Long Read Sequencing nanRECRUITING
Gene Modifiers of Cystic Fibrosis Lung Disease nanACTIVE_NOT_RECRUITING
BIG Molecular Screening Feasibility Study nanCOMPLETED
PCM1-JAK2 in Therapy Related Neoplasms nanUNKNOWN
Family Study of Melanoma in Italy nanCOMPLETED
Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a INTS9 binder may also engage these)

ProteinNameSimilarity
Q8K114 1.000 Q8K114 →
Q2KJA6 1.000 Q2KJA6 →
Q4R5Z4 1.000 Q4R5Z4 →
Q6DFF4 0.999 Q6DFF4 →
Q5ZKK2 0.997 Q5ZKK2 →
Q5E9L7 0.973 Q5E9L7 →
Q5ZJV4 0.973 Q5ZJV4 →
Q6NYU2 0.972 Q6NYU2 →
A4GWN3 0.970 A4GWN3 →
Q9H269 0.970 Q9H269 →
Q5RGJ5 0.970 Q5RGJ5 →
Q80YQ8 0.969 Q80YQ8 →
Q5R8R4 0.969 Q5R8R4 →
P82922 0.968 P82922 →
Q9W799 0.968 Q9W799 →
Q28C34 0.968 Q28C34 →
Q9NXN4 0.968 Q9NXN4 →
Q920Q4 0.967 Q920Q4 →
ERCC4 DNA repair endonuclease XPF (EC 3.1.-.-) (DNA 0.967 landscape →
A5PJM5 0.966 A5PJM5 →
Q91W86 0.966 Q91W86 →
B1H268 0.966 B1H268 →
Q9QZD4 0.966 Q9QZD4 →
Q8QFR2 0.966 Q8QFR2 →
Q32LU1 0.966 Q32LU1 →
P48553 0.966 P48553 →
GTF3C3 General transcription factor 3C polypeptide 3 0.966 landscape →
Q9ER88 0.966 Q9ER88 →
Q9QYM7 0.966 Q9QYM7 →
Q6EDY6 0.965 Q6EDY6 →